Sen. Bernie Sanders (I-Vt.) declined to accept a maximum campaign donation from the CEO of a company that increased the price of a drug used by HIV and AIDS patients by hundreds of dollars, choosing instead to donate the money to a Washington health clinic.
Martin Shkreli, CEO of Turing Pharmaceuticals, donated $2,700, the maximum allowed for individual donors, in September, he told Stat. While the Sanders campaign initially thanked Shkreli for his contribution, a campaign spokesman told Stat this week that it would donate the money to Whitman-Walker health clinic.
Shkreli, who raised the price of Daraprim from $13.50 to $750 per tablet after acquiring it in August, told Stat that he donated in part to get a meeting with Sanders to explain how drug prices were set. Sanders has refused to meet with him.
After backlash over the sudden increase, Shkreli said in September that the company would lower the price. At the beginning of October, ABC News found that the price still remained extremely high.